D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Alibaba
BABA
|
+$655M |
| 2 |
NVIDIA
NVDA
|
+$579M |
| 3 |
Amazon
AMZN
|
+$425M |
| 4 |
ConocoPhillips
COP
|
+$423M |
| 5 |
Johnson & Johnson
JNJ
|
+$380M |
Top Sells
| 1 |
Qualcomm
QCOM
|
+$868M |
| 2 |
Meta Platforms (Facebook)
META
|
+$554M |
| 3 |
Apple
AAPL
|
+$461M |
| 4 |
CELG
Celgene Corp
CELG
|
+$339M |
| 5 |
Pfizer
PFE
|
+$316M |
Sector Composition
| 1 | Technology | 19.2% |
| 2 | Consumer Discretionary | 16.83% |
| 3 | Healthcare | 16.01% |
| 4 | Industrials | 8.99% |
| 5 | Financials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1426
FNB Corp
FNB
$5.89B
| $2.76M | ﹤0.01% |
234,496
+102,347
| +77% | +$1.2M |
|
1427
Commercial Vehicle Group
CVGI
$72.9M
| $2.76M | ﹤0.01% |
344,042
+98,685
| +40% | +$791K |
|
|
TACO
1428
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
| $2.75M | ﹤0.01% |
214,553
+69,812
| +48% | +$895K |
|
1429
Titan International
TWI
$552M
| $2.75M | ﹤0.01% |
561,879
+102,850
| +22% | +$503K |
|
1430
Noodles & Co
NDLS
$30.7M
| $2.73M | ﹤0.01% |
346,457
+102,935
| +42% | +$811K |
|
1431
Public Storage
PSA
$51.3B
| $2.73M | ﹤0.01% |
11,455
-1,725
| -13% | -$411K |
|
|
WDR
1432
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $2.72M | ﹤0.01% |
163,148
+123,879
| +315% | +$2.07M |
|
1433
Meritage Homes
MTH
$5.61B
| $2.71M | ﹤0.01% |
105,488
-190,370
| -64% | -$4.89M |
|
1434
Oaktree Specialty Lending
OCSL
$1.21B
| $2.7M | ﹤0.01% |
166,346
+22,068
| +15% | +$359K |
|
|
AZPN
1435
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $2.7M | ﹤0.01% |
21,691
-48,162
| -69% | -$5.99M |
|
|
ACOR
1436
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $2.69M | ﹤0.01% |
2,922
+1,406
| +93% | +$1.29M |
|
1437
Heritage Commerce
HTBK
$624M
| $2.69M | ﹤0.01% |
219,279
+56,797
| +35% | +$696K |
|
|
CURO
1438
DELISTED
CURO Group Holdings Corp.
CURO
| $2.69M | ﹤0.01% |
243,094
-42,997
| -15% | -$475K |
|
|
ENDP
1439
DELISTED
Endo International plc
ENDP
| $2.68M | ﹤0.01% |
651,257
-1,113,434
| -63% | -$4.59M |
|
1440
TETRA Technologies
TTI
$630M
| $2.67M | ﹤0.01% |
1,638,558
+102,976
| +7% | +$168K |
|
1441
Tetra Tech
TTEK
$9.5B
| $2.66M | ﹤0.01% |
169,515
-191,870
| -53% | -$3.01M |
|
1442
First Bancorp
FBNC
$2.29B
| $2.65M | ﹤0.01% |
72,893
+6,286
| +9% | +$229K |
|
|
ROIC
1443
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $2.65M | ﹤0.01% |
154,846
-43,666
| -22% | -$748K |
|
|
TEN
1444
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $2.63M | ﹤0.01% |
237,410
-7,553
| -3% | -$83.8K |
|
1445
Banco Santander Chile
BSAC
$12.1B
| $2.63M | ﹤0.01% |
87,868
-24,841
| -22% | -$743K |
|
1446
Cushman & Wakefield
CWK
$3.85B
| $2.63M | ﹤0.01% |
147,036
+46,711
| +47% | +$835K |
|
1447
Enphase Energy
ENPH
$4.92B
| $2.63M | ﹤0.01% |
143,977
+106,474
| +284% | +$1.94M |
|
1448
Ingevity
NGVT
$2.12B
| $2.62M | ﹤0.01% |
24,937
-64,606
| -72% | -$6.8M |
|
1449
Nova
NVMI
$8.69B
| $2.62M | ﹤0.01% |
102,500
+50,971
| +99% | +$1.3M |
|
1450
Jazz Pharmaceuticals
JAZZ
$7.65B
| $2.62M | ﹤0.01% |
18,380
-73,446
| -80% | -$10.5M |
|